Skip to Content

Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension. Pandemic influenza vaccine (H5N1) (live attenuated, nasal).

Licence status
Authorised: 20/05/2016
Active substances
Strain. a/vietnam/1203/2004 (h5n1) strain (live attenuated)
Dosage Form
Nasal spray, suspension
Licence number
EU/1/16/1089/001
Licence holder
AstraZeneca AB

Licence information

ATC code
J07BB Influenza vaccines, J07BB03 influenza, live attenuated
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/05/2016